Whole blood samples from healthy volunteers and patients with CLL incubated for 2 h with increasing concentrations of tirabrutinib showed at 110 nM a 90% Btk occupancy, but Btk occupancy of bone marrow cells and lymph node tissue from patients with CLL was not determined. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.